# Phase 1 PK Interaction Study Between VX-509 and Prednisone or Methylprednisolone in Healthy Male Subjects

> **NCT01886209** · PHASE1 · COMPLETED · sponsor: **Vertex Pharmaceuticals Incorporated** · enrollment: 28 (estimated)

## Conditions studied

- Drug Interactions

## Interventions

- **DRUG:** Prednisone
- **DRUG:** VX-509
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT01886209
- **Lead sponsor:** Vertex Pharmaceuticals Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2013-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01886209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01886209, "Phase 1 PK Interaction Study Between VX-509 and Prednisone or Methylprednisolone in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01886209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*